doi: 10.3390/ani10122281 91 SafaS.MoghaddamG.JozaniR
10.3892/or.2013.2495 29 LiJ
In clinical contexts, GSH capsules may aid in managing conditions linked to oxidative imbalance, such as neurodegenerative disorders (e.g., Alzheimer's and Parkinson's disease), liver diseases (e.g., non-alcoholic fatty liver disease), and respiratory ailments (e.g., chronic obstructive pulmonary disease)
Inhibition of kynurenine 3-monooxygenase (KMO) significantly suppressed XA elevation and attenuated both oxygen-glucose deprivation (OGD)-induced cardiomyocyte injury and ligation-induced myocardial ischemia injury, suggesting XA's potential utility as a ferroptosis marker in CAD
In this paper, we focus on the first objective, while the second provides the future direction of this research